Cargando…

Targeting MYC-driven lymphoma: lessons learned and future directions

MYC plays a central role in tumorigenesis by orchestrating cell proliferation, growth and survival, among other transformation mechanisms. In particular, MYC has often been associated with lymphomagenesis. In fact, MYC overexpressing lymphomas such as high-grade B-cell lymphoma (HGBL) and double exp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martínez-Martín, Sandra, Beaulieu, Marie-Eve, Soucek, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	OAE Publishing Inc. 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344726/ https://www.ncbi.nlm.nih.gov/pubmed/37457123 http://dx.doi.org/10.20517/cdr.2022.127

Ejemplares similares

Structural and Biophysical Insights into the Function of the Intrinsically Disordered Myc Oncoprotein
por: Beaulieu, Marie-Eve, et al.
Publicado: (2020)

Strategies to Inhibit Myc and Their Clinical Applicability
por: Whitfield, Jonathan R., et al.
Publicado: (2017)

MYC inhibitors in multiple myeloma
por: Martínez-Martín, Sandra, et al.
Publicado: (2021)

The Wnt signaling receptor Fzd9 is essential for Myc-driven tumorigenesis in pancreatic islets
por: Zacarías-Fluck, Mariano F, et al.
Publicado: (2021)

Fragile X targeted pharmacotherapy: lessons learned and future directions
por: Erickson, Craig A., et al.
Publicado: (2017)

The Molecular ‘Myc-anisms’ Behind Myc-Driven Tumorigenesis and the Relevant Myc-Directed Therapeutics
por: McAnulty, Jessica, et al.
Publicado: (2020)

Finding MYCure
por: Beaulieu, Marie-Eve, et al.
Publicado: (2019)

Tumor microenvironment: becoming sick of Myc
por: Whitfield, Jonathan R., et al.
Publicado: (2011)

BET inhibition is an effective approach against KRAS-driven PDAC and NSCLC
por: Jauset, Toni, et al.
Publicado: (2018)

The mitochondrial translation machinery as a therapeutic target in Myc-driven lymphomas
por: D'Andrea, Aleco, et al.
Publicado: (2016)

Targeting Translation Initiation by Synthetic Rocaglates for Treating MYC-driven Lymphomas
por: Zhang, Xuan, et al.
Publicado: (2019)

Blocking Myc to Treat Cancer: Reflecting on Two Decades of Omomyc
por: Massó-Vallés, Daniel, et al.
Publicado: (2020)

Lessons from Using Genetically Engineered Mouse Models of MYC-Induced Lymphoma
por: Winkler, René, et al.
Publicado: (2022)

COVID-19 pandemic: Lessons learned and future directions
por: Khanna, Rohit C, et al.
Publicado: (2020)

Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanoma
por: Zacarías-Fluck, Mariano F., et al.
Publicado: (2023)

Therapeutic Approaches Targeting MYC-Driven Prostate Cancer
por: Rebello, Richard J., et al.
Publicado: (2017)

IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E-myc Mice
por: Vecchio, Eleonora, et al.
Publicado: (2020)

State of the art of ICD programming: Lessons learned and future directions
por: Mastenbroek, M. H., et al.
Publicado: (2014)

PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma
por: D’Avola, Annalisa, et al.
Publicado: (2022)

Myc inhibition is effective against glioma and reveals a role for Myc in proficient mitosis
por: Annibali, Daniela, et al.
Publicado: (2014)

Patent Ductus Arteriosus Clinical Trials: Lessons Learned and Future Directions
por: Smith, Aisling, et al.
Publicado: (2021)

The Effects of the COVID Pandemic on Patients with IBD: Lessons Learned and Future Directions
por: Zhang, Eva, et al.
Publicado: (2022)

Machine Learning and Radiogenomics: Lessons Learned and Future Directions
por: Kang, John, et al.
Publicado: (2018)

Experimental Models to Study End-Organ Morbidity in Sleep Apnea: Lessons Learned and Future Directions
por: Farré, Ramon, et al.
Publicado: (2022)

Cancer chemoprevention: lessons learned and future directions
por: Brenner, D E, et al.
Publicado: (2005)

Anthrax Bioterrorism: Lessons Learned and Future Directions
por: Hughes, James M., et al.
Publicado: (2002)

MYC-driven aggressive B-cell lymphomas: biology, entity, differential diagnosis and clinical management
por: Cai, Qingqing, et al.
Publicado: (2015)

RNAi for Western Corn Rootworm Management: Lessons Learned, Challenges, and Future Directions
por: Darlington, Molly, et al.
Publicado: (2022)

The Action Mechanism of the Myc Inhibitor Termed Omomyc May Give Clues on How to Target Myc for Cancer Therapy
por: Savino, Mauro, et al.
Publicado: (2011)

The long journey to bring a Myc inhibitor to the clinic
por: Whitfield, Jonathan R., et al.
Publicado: (2021)

Tuberous sclerosis complex is required for tumor maintenance in MYC‐driven Burkitt's lymphoma
por: Hartleben, Götz, et al.
Publicado: (2018)

Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions
por: Geetha, Duvuru, et al.
Publicado: (2022)

Immunohistochemical Detection of MYC-driven Diffuse Large B-Cell Lymphomas
por: Kluk, Michael J., et al.
Publicado: (2012)

The direct Myc target Pim3 cooperates with other Pim kinases in supporting viability of Myc-induced B-cell lymphomas
por: Forshell, Linus Plym, et al.
Publicado: (2011)

Oxidative stress enhances the therapeutic action of a respiratory inhibitor in MYC‐driven lymphoma
por: Donati, Giulio, et al.
Publicado: (2023)

Advances in the field of intranasal oxytocin research: lessons learned and future directions for clinical research
por: Quintana, Daniel S., et al.
Publicado: (2020)

MYC-Driven Pathways in Breast Cancer Subtypes
por: Fallah, Yassi, et al.
Publicado: (2017)

Gene Transactivation and Transrepression in MYC-Driven Cancers
por: Scafuro, Marika, et al.
Publicado: (2021)

Dementia Incidence on the Decline in Korea: Lessons Learned and Future Directions
por: Cho, Seong-Jin, et al.
Publicado: (2019)

MYC Inhibition Halts Metastatic Breast Cancer Progression by Blocking Growth, Invasion, and Seeding
por: Massó-Vallés, Daniel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jk12m9c2vb32tpfi9p83dv78g5